共 129 条
Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain ?-keto acids
被引:24
作者:
Amaral, Alexandre Umpierrez
[1
,2
]
Wajner, Moacir
[2
,3
,4
,5
]
机构:
[1] Univ Reg Integrada Alto Uruguai & Missoes, Dept Ciencias Biol, Erechim, Rio Grande do S, Brazil
[2] Univ Fed Rio Grande, Programa Posgraduacao Ciencias Biol Bioquim, Inst Ciencias Bas Saude, Porto Alegre, Rio Grande do S, Brazil
[3] Univ Fed Rio Grande, Dept Bioquim, Inst Ciencias Bas Saude, Porto Alegre, Rio Grande do S, Brazil
[4] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, Rio Grande do S, Brazil
[5] Univ Fed Rio Grande, Dept Bioquim, Inst Ciencias Bas Saude, Rua Ramiro Barcelos, 2600-Anexo, BR-90035003 Porto Alegre, Rio Grande do S, Brazil
关键词:
Maple syrup urine disease;
Branched-chain amino acids;
Branched-chain ?-keto acids;
Bioenergetics;
Redox homeostasis;
Neuroinflammation;
CREATINE-KINASE ACTIVITY;
BRAIN ENERGY-METABOLISM;
INDUCE MORPHOLOGICAL ALTERATIONS;
L-CARNITINE;
OXIDATIVE STRESS;
CATHEPSIN-D;
RAT-BRAIN;
ALPHA-KETOISOCAPROATE;
LIPID-PEROXIDATION;
REACTIVE OXYGEN;
D O I:
10.1016/j.neuint.2022.105360
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Maple syrup urine disease (MSUD) is an autosomal recessive neurometabolic disorder caused by severe deficiency of branched-chain alpha-keto acid dehydrogenase complex activity, which catalyzes the oxidative decarboxylation of the branched-chain alpha-keto acids (BCKA). The metabolic blockage results in tissue accumulation and high urinary excretion of the branched-chain amino acids (BCAA) leucine, isoleucine and valine, as well as alloisoleucine, and their respective BCKA alpha-ketoisocaproic (alpha-KIC), alpha-ketoisovaleric and alpha-keto-beta-methylvaleric acids. Affected patients usually manifest acute episodes of encephalopathy associated with seizures, coma and life-threatening cerebral edema in the first weeks of life, which is followed by progressive neurological deterioration with motor delay, ataxia, intellectual disability and psychiatric symptoms. The pathophysiology of the brain damage in MSUD has been mainly focused on brain amino acid imbalance leading to deficient cerebral protein and neurotransmitter synthesis. However, the acute episodes of severe neurological symptoms accompanied by large increases of BCKA/BCAA levels suggest neurotoxic actions of these compounds. In this particular, mounting evidence from humans and animal models support an important role of particularly leucine and alpha-KIC on the pathogenesis of the brain injury in MSUD. In this review we will present the current knowledge of the major mechanisms presumably involved in MSUD neuropathology and highlight the neurotoxic properties of the BCAA and BCKA, disturbing brain bioenergetics and redox homeostasis, besides inducing neuroinflammation. We suggest that these pathomechanisms may contribute to the neurological sequelae of MSUD patients and hopefully allow the design of novel therapeutic strategies, including antioxidant and bioenergetics stimulating drugs targeting the mitochondria.
引用
收藏
页数:14
相关论文